Cargando…
Immunolocalization of IL-6 and IL-10 in the testicular tissue of testicular dysfunction rat treated with secretome
OBJECTIVE: This study was carried out to find out the immunolocalization of Interleukin 6 (IL-6) and Interleukin 10 (IL-10) in the testicular tissue of testicular dysfunction rat treated with secretome from human umbilical stem cells. MATERIALS AND METHODS: Rats were induced with cisplatin for testi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
A periodical of the Network for the Veterinarians of Bangladesh (BDvetNET)
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521813/ https://www.ncbi.nlm.nih.gov/pubmed/33005678 http://dx.doi.org/10.5455/javar.2020.g448 |
_version_ | 1783588050114183168 |
---|---|
author | Prihatno, Surya Agus Adi, Yosua Kristian Budipitojo, Teguh |
author_facet | Prihatno, Surya Agus Adi, Yosua Kristian Budipitojo, Teguh |
author_sort | Prihatno, Surya Agus |
collection | PubMed |
description | OBJECTIVE: This study was carried out to find out the immunolocalization of Interleukin 6 (IL-6) and Interleukin 10 (IL-10) in the testicular tissue of testicular dysfunction rat treated with secretome from human umbilical stem cells. MATERIALS AND METHODS: Rats were induced with cisplatin for testicular dysfunction condition. After that, the rats were grouped into two categories and were treated with secretome at 0.2 and 0.5 ml/kg BW once every week for 4 weeks. One week later, after the secretome treatment, the rats were sacrificed for histological evaluation using the immunohistochemical method. The preparation slides were examined using a light microscope and were analyzed descriptively and quantitatively. RESULTS: There were no IL-6 and IL-10 immunoreactivities seen in the testicular tissue after cisplatin induction. However, the immunoreactivities of IL-6 and IL-10 were detected after secretome treatment, with both dosages of 0.2 and 0.5 ml/kg BW. These immunoreactivities were detected in the spermatogonia, spermatid/luminal tissue of seminiferous tubule, spermatogenic cells, and Leydig cells. In the cell calculation, the numbers of IL-6 immunoreactive cells were higher at the lower secretome dosage. In contrast, the numbers of IL-10 immunoreactive cells were higher at the higher secretome dosage. CONCLUSION: IL-6 and IL-10 can be localized in the testicular tissue of testicular dysfunction rat after secretome treatment. |
format | Online Article Text |
id | pubmed-7521813 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | A periodical of the Network for the Veterinarians of Bangladesh (BDvetNET) |
record_format | MEDLINE/PubMed |
spelling | pubmed-75218132020-09-30 Immunolocalization of IL-6 and IL-10 in the testicular tissue of testicular dysfunction rat treated with secretome Prihatno, Surya Agus Adi, Yosua Kristian Budipitojo, Teguh J Adv Vet Anim Res Original Article OBJECTIVE: This study was carried out to find out the immunolocalization of Interleukin 6 (IL-6) and Interleukin 10 (IL-10) in the testicular tissue of testicular dysfunction rat treated with secretome from human umbilical stem cells. MATERIALS AND METHODS: Rats were induced with cisplatin for testicular dysfunction condition. After that, the rats were grouped into two categories and were treated with secretome at 0.2 and 0.5 ml/kg BW once every week for 4 weeks. One week later, after the secretome treatment, the rats were sacrificed for histological evaluation using the immunohistochemical method. The preparation slides were examined using a light microscope and were analyzed descriptively and quantitatively. RESULTS: There were no IL-6 and IL-10 immunoreactivities seen in the testicular tissue after cisplatin induction. However, the immunoreactivities of IL-6 and IL-10 were detected after secretome treatment, with both dosages of 0.2 and 0.5 ml/kg BW. These immunoreactivities were detected in the spermatogonia, spermatid/luminal tissue of seminiferous tubule, spermatogenic cells, and Leydig cells. In the cell calculation, the numbers of IL-6 immunoreactive cells were higher at the lower secretome dosage. In contrast, the numbers of IL-10 immunoreactive cells were higher at the higher secretome dosage. CONCLUSION: IL-6 and IL-10 can be localized in the testicular tissue of testicular dysfunction rat after secretome treatment. A periodical of the Network for the Veterinarians of Bangladesh (BDvetNET) 2020-08-22 /pmc/articles/PMC7521813/ /pubmed/33005678 http://dx.doi.org/10.5455/javar.2020.g448 Text en Copyright: © Journal of Advanced Veterinary and Animal Research http://creativecommons.org/licenses/by-nc/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Prihatno, Surya Agus Adi, Yosua Kristian Budipitojo, Teguh Immunolocalization of IL-6 and IL-10 in the testicular tissue of testicular dysfunction rat treated with secretome |
title | Immunolocalization of IL-6 and IL-10 in the testicular tissue of testicular dysfunction rat treated with secretome |
title_full | Immunolocalization of IL-6 and IL-10 in the testicular tissue of testicular dysfunction rat treated with secretome |
title_fullStr | Immunolocalization of IL-6 and IL-10 in the testicular tissue of testicular dysfunction rat treated with secretome |
title_full_unstemmed | Immunolocalization of IL-6 and IL-10 in the testicular tissue of testicular dysfunction rat treated with secretome |
title_short | Immunolocalization of IL-6 and IL-10 in the testicular tissue of testicular dysfunction rat treated with secretome |
title_sort | immunolocalization of il-6 and il-10 in the testicular tissue of testicular dysfunction rat treated with secretome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521813/ https://www.ncbi.nlm.nih.gov/pubmed/33005678 http://dx.doi.org/10.5455/javar.2020.g448 |
work_keys_str_mv | AT prihatnosuryaagus immunolocalizationofil6andil10inthetesticulartissueoftesticulardysfunctionrattreatedwithsecretome AT adiyosuakristian immunolocalizationofil6andil10inthetesticulartissueoftesticulardysfunctionrattreatedwithsecretome AT budipitojoteguh immunolocalizationofil6andil10inthetesticulartissueoftesticulardysfunctionrattreatedwithsecretome |